What is it about?
ME/CSF are rare conditions, and as a result the lack of detailed medical records and of high numbers of medical records, make the discovery of biomarkers that would predict disease progression very challenging. Two computational methods (digital twin and synthetic data) have the potential to address these two challenges, at least in part. The potential implementations are discussed in the manuscript.
Featured Image
Read the Original
This page is a summary of: Applying a Digital Twin Approach for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Innovations in Digital Health Diagnostics and Biomarkers, January 2023, Innovative Healthcare Institute,
DOI: 10.36401/iddb-23-4.
You can read the full text:
Contributors
Be the first to contribute to this page